Program: Sunday (04.11.2007)

08:30 – 10:00

Room: Großer Saal

Scientific Session Characterization of HRS Cells and "Stem Cells" in HL

  • Richard Ambinder
  • Ralf Küppers
  • Molecular Immunogenetics of B Cells and HRS Cells

    • Ralf Küppers
  • Translocations in HRS Cells

    • Reiner Siebert
  • The Plasticity of HRS Cells

    • Stephan Mathas
  • The Role of microRNA for Regulation of PRDM1/Blimp-1in HRS Cells

    • Wayne Tam
  • BIC and other miRNAs in HL

    • Anke van den Berg
  • HL: Evidence for a Cancer Stem Cell and Therapeutic Implications

    • Richard Ambinder
  • Induction of Hodgkin-like Phenotype by Epigenetic Reprogramming of B Cells

    • Michael Hummel
  • 3D Nuclear Organization of Telomeres in HRS Cells

    • Hans Knecht

10:30 – 12:00

Room: Großer Saal

Scientific Session Scientific Session on Translational Approaches

  • Michel Henry-Amar
  • Anas Younes
  • Antiangiogenic Agents

    • Peter Borchmann
  • KLHDC8B: a Candidate HL Susceptibility Gene

    • Matthew Mealiffe
  • Analysis of Genetic Predisposition to Hematotoxicity in HL

    • Daniel Re
  • Serum Profiling of Cytokines

    • Olivier Casasnovas
  • Targeted Treatment Approaches in HL

    • Martin Janz
  • How to Select Novel Small Molecules for Early Clinical Testing

    • Anas Younes
  • Proteomics Analysis of HL: Identification of New Players Involved in the Cross Talk between HRS Cells and Infiltrating Lymphocytes

    • Yue Ma
  • Galectin 1 Mediates Tumor Escape in HL

    • Margaret Shipp

12:15 – 13:45

Room: Großer Saal

Satellite Symposium (by Amgen GmbH) Prophylaxis and Treatment of Side Effects of Chemotherapy: Casuistic Forum

  • Anton Hagenbeek
  • Lorenz Trümper
  • Anaemia in Patients with Hodgkin Lymphoma

    • Anders Österborg
  • Neutropenia in Patients with Aggressive NHL

    • Frank Hartmann
  • Mucositis in Patients with Relapsed Lymphoma

    • Guido Kobbe
  • Concluding Remarks

    • Anton Hagenbeek
    • Lorenz Trümper

14:00 – 15:30

Room: Großer Saal

Satellite Symposium (by Ortho-Biotech) Innovative Strategies in the Therapy of Hematological Malignancies

  • Andreas Engert
  • Michael Hallek
  • Velcade – Lead Compound in Multiple Myeloma?

    • Martin Kropff
  • Future Directions in the Treatment of MDS

    • Ulrich Germing
  • Velcade – Innovative Therapy Options in NHL

    • Martin Gramatzki
  • Efficient Hb Management in Lymphoma: Results of the HD15 Protocol

    • Andreas Engert

16:00 – 17:30

Room: Großer Saal

Satellite Symposium (by Roche Pharma AG) Treatment of Lymphomas: Current Strategies and Future Outlook

  • Andreas Engert
  • Clemens Wendtner
  • Pathogenesis of B-Cell Lymphomas and Identification of Molecules Suitable for Targeted Therapy

    • Ioannis Anagnostopoulos
  • Review of Immuno-Chemotherapy in Aggressive and Follicular Lymphoma

    • Mathias Rummel
  • State of the Art Therapy Non Hodgkin Lymphoma in the USA

    • Richard Fisher
  • Role of Immuno-Chemotherapy in HL

    • Anas Younes
  • New treatment approaches in Aggressive Lymphoma: Intensified Immuno-Chemotherapy - Anti-VEGF + Immuno-Chemotherapy

    • Michael Pfreundschuh
  • New Treatment Approaches in HL: Emergence of Anti-VEGF as a New Modality in HL

    • Andreas Engert

17:30 – 20:00

Room: Großer Saal

Main Program Opening Ceremony

  • From the Absorbent Gland to the “Molecular Cure” of Hodgkin Lymphoma

    • Volker Diehl


Room: Weinkeller

Main Program Kick-off party


You a viewing the program of a past symposium. Click here to get back to the current conference.